Vivo Energy is a Royal Dutch Shell and Engen Petroleum licensee and sources, distributes, markets and supplies fuels and lubricants. It is listed on the London Stock Exchange and the Johannesburg Stock Exchange and is a constituent of the FTSE 250 Index and of the JSE All Share Index.
Is VIVO a good buy?
The financial health and growth prospects of VIVO, demonstrate its potential to outperform the market. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.
How do I buy VIVO stock?
Shares of VIVO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When did Meridian Bioscience go public?
Meridian went public in 1986 and trades on NASDAQ (VIVO).
How do I make a Vivo company?
Vivo is an independent company and develops its own products. It has 10,000 employees, with research and development centers in Shenzhen, Guangdong, and Nanjing, Jiangsu….Vivo (technology company)
| Industry | Consumer electronics |
| Founded | 2009 |
| Founder | Shen Wei (沈炜) |
| Headquarters | Dongguan, Guangdong , China |
| Chinese name |
|---|
What is Vivo phone?
Vivo Electronics Corp. is a phone brand based in Dongguan, Guangdong, China. It was founded in 2009. The company is another Chinese smartphone maker to enter India recently. It makes low-cost Android phones, and those in the mid-range segment of the market.
What does Meridian Bioscience do?
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, rare reagents, specialty biologicals and components.
Where is Meridian Bioscience located?
The Company offers testing platforms and technologies. These products are primarily used in the detection of infectious diseases caused by various bacteria, viruses, parasites, and pathogens….Overview Suggest Edit.
| Type | Public | |
|---|---|---|
| Founded | 1977 | |
| HQ | Cincinnati, OH, US | Map |
| Website | meridianbioscience.com | |
| Employee Ratings | 2.2 | More |
Who is Vivo owned by?
BBK Electronics
Headquartered in Dongguan, Vivo is a Chinese electronics brand founded by Shen Wei in 2009. Owned by BBK Electronics, Vivo designs and sells smartphones, software and phone accessories.
How much is Vivo V21 Pro?
Vivo V21 Pro price in India is expected to be Rs. 32,990. Vivo V21 Pro Expected to be launched on Dec 18, 2021.
Who is owner of Vivo?
Vivo/Parent organizations
What does Meridian Bioscience make?
diagnostic test kits
Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain gastrointestinal and respiratory infectious diseases and elevated blood lead levels.
What is the last traded price of vivo Bio Tech Ltd stock?
Vivo Bio Tech Ltd. share price moved down by -3.12 % from its previous close of Rs 97.65. Vivo Bio Tech Ltd. stock last traded price is 94.60 DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data).
Where can I buy vivo shares?
Shares of VIVO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Meridian Bioscience’s stock price today?
Who bought valuevivo stock in the last quarter?
VIVO stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Fort Washington Investment Advisors Inc. OH, Kempen Capital Management N.V., Acuitas Investments LLC, State Street Corp, Systematic Financial Management LP, Millennium Management LLC, and Fuller & Thaler Asset Management Inc..
Does meritmeridian Bioscience (vivo) stock deliver strong earnings and revenue surprises?
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of -29.03% and -13.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
